The desired sample size was 200 ventilator-dependent patients or 2,000 ... than 24 hours and did not have a previous diagnosis of pneumonia. patients with AIDS secondary to immunocompromised ...

The risk for ventilator-associated pneumonia (VAP) in patients receiving mechanical ventilation in the ICU is less in those ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. Everything about ventilator associated pneumonia is contentious. What is the microbial ...

(KSP-1007 + meropenem) is under clinical development by Sumitomo Pharma and currently in Phase I for Ventilator Associated Pneumonia (VAP). According to GlobalData, Phase I drugs for Ventilator ...

The new treatment is for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP). The two conditions are rampant across Indian hospitals where patients ...

StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note released on Sunday. The brokerage issued a hold rating on the specialty ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Detailed price information for Aridis Pharmaceuticals Inc (ARDS) from The Globe and Mail including charting and trades.

Development status: AR-301 is being evaluated for the adjunctive therapeutic treatment of Ventilator Associated Pneumonia (VAP). The first of two planned Phase 3 clinical trials saw significant ...

A recent study found that obesity is one of the deciding factors for the length of hospital stay and the dependency on ...

With Carina ®,Dräger has developed an innovative,high performance NIV ventilator that is comfortable for both the patient and the caregiver. This compact, mobile unit optimizes workflow and ...

抗微生物药物耐药性（AMR）已成为全球亟待解决的重大公共卫生挑战，对人类健康构成严重威胁。随着AMR问题的日益严峻，全球及我国在细菌耐药流行趋势、新型抗感染治疗药物研发等方面均出现了新的变化。为全面梳理这些进展，《感染医线》特邀中华医学会细菌感染与耐药防治分会主任委员、复旦大学附属华山医院抗生素研究所所长 ...